April 15, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 96,756 shares of Revolution Medicines, Inc. at $4.73 per share, a transaction worth $457.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 201,150 restricted stock units.